Triple-negative breast cancer (TNBC), is a heterogeneous disease characterised by negative expression of the estrogen receptor (ER), progesterone receptor (PR) and lack of overexpression of the human epidermal growth factor receptor 2 (HER2) [1]. Here, ERBB2 is linked to triple-negative breast carcinoma.